Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study-Reference-Cited by-同舟云学术

Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study

Published:2019-02-09 Issue:8 Volume:21 Page:1093-1103
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Amraee A.,Evazi M. R.,Shakeri M.,Roozbeh N.,Ghazanfarpour M.,Ghorbani M.,Ansari J.,Darvish L.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s12094-018-02032-4/fulltext.html

Reference39 articles.

1. Makita S, Maruyama D, Maeshima AM, et al. Clinical features and outcomes of 139 Japanese patients with Hodgkin lymphoma. Int J Hematol. 2016;104(2):233–44.

2. Ogura M, Itoh K, Kinoshita T, et al. Phase II study of ABVd therapy for newly diagnosed clinical stage II–IV Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG 9305). Int J Hematol. 2010;92(5):713–24.

3. Keir ME, Butte MJ, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677–704.

4. Weber J. Immune checkpoint proteins: a new therapeutic paradigm for cancer—preclinical background: CTLA-4 and PD-1 blockade. Semin Oncol. 2010;37(5):430–9.

5. Brahmer JR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-L1 anti-body in patients with advanced cancer. N Engl J Med. 2012;366(26):2455–65.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020;Scientific Reports;2024-09-03

2. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis;Journal of Hematology & Oncology;2022-05-11

3. A role of interim positron emission tomography/computed tomography scan in the management of Hodgkin lymphoma: A single-center study in a developing country;Iraqi Journal of Hematology;2022

4. From Anti-PD-1/PD-L1 to CTLA-4 and to MUC1—Is the Better Response to Treatment in Smokers of Cancer Patients Drug Specific?;Journal of Personalized Medicine;2021-09-13

5. Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?;Human Vaccines & Immunotherapeutics;2021-06-08